| Annette Denise Caple, NP | |
|
1300 Wesley Dr, Memphis, TN 38116-6426 | |
| (901) 395-2618 | |
| (901) 385-3261 |
| Full Name | Annette Denise Caple |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1300 Wesley Dr, Memphis, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013250166 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 0000017385 (Tennessee) | Primary |
| Entity Name | Mid-south Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780017228 PECOS PAC ID: 4587891981 Enrollment ID: O20131210001338 |
News Archive
BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.
The Clemson family has gained a new namesake: Legionella clemsonensis, a novel strain of the Legionella bacteria, the most common cause of waterborne bacterial outbreaks in the United States.
New research has revealed that older adults who regularly golf could be at a lower risk of death compared to those who do not play. The results of this research are to be presented at the American Stroke Association's International Stroke Conference 2020 in Los Angeles between the 19th and 21st of February 2020.
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your electric bill and carbon footprint?
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
› Verified 1 days ago
| Entity Name | Cordova Pain Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437565900 PECOS PAC ID: 1759500523 Enrollment ID: O20140910001813 |
News Archive
BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.
The Clemson family has gained a new namesake: Legionella clemsonensis, a novel strain of the Legionella bacteria, the most common cause of waterborne bacterial outbreaks in the United States.
New research has revealed that older adults who regularly golf could be at a lower risk of death compared to those who do not play. The results of this research are to be presented at the American Stroke Association's International Stroke Conference 2020 in Los Angeles between the 19th and 21st of February 2020.
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your electric bill and carbon footprint?
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
› Verified 1 days ago
| Entity Name | Ideal Health Solutions, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811442452 PECOS PAC ID: 3577843218 Enrollment ID: O20161215000102 |
News Archive
BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.
The Clemson family has gained a new namesake: Legionella clemsonensis, a novel strain of the Legionella bacteria, the most common cause of waterborne bacterial outbreaks in the United States.
New research has revealed that older adults who regularly golf could be at a lower risk of death compared to those who do not play. The results of this research are to be presented at the American Stroke Association's International Stroke Conference 2020 in Los Angeles between the 19th and 21st of February 2020.
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your electric bill and carbon footprint?
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
› Verified 1 days ago
| Entity Name | Integrated Wound Care Tennessee Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215593991 PECOS PAC ID: 8527394477 Enrollment ID: O20190730002619 |
News Archive
BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.
The Clemson family has gained a new namesake: Legionella clemsonensis, a novel strain of the Legionella bacteria, the most common cause of waterborne bacterial outbreaks in the United States.
New research has revealed that older adults who regularly golf could be at a lower risk of death compared to those who do not play. The results of this research are to be presented at the American Stroke Association's International Stroke Conference 2020 in Los Angeles between the 19th and 21st of February 2020.
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your electric bill and carbon footprint?
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Annette Denise Caple, NP P O Box 1000 Dept 351, Memphis, TN 38148-0001 Ph: (901) 758-9900 | Annette Denise Caple, NP 1300 Wesley Dr, Memphis, TN 38116-6426 Ph: (901) 395-2618 |
News Archive
BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.
The Clemson family has gained a new namesake: Legionella clemsonensis, a novel strain of the Legionella bacteria, the most common cause of waterborne bacterial outbreaks in the United States.
New research has revealed that older adults who regularly golf could be at a lower risk of death compared to those who do not play. The results of this research are to be presented at the American Stroke Association's International Stroke Conference 2020 in Los Angeles between the 19th and 21st of February 2020.
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your electric bill and carbon footprint?
TenX Biopharma, Inc. announced today that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for cutaneous T-cell lymphoma (CTCL) patients (ClinicalTrials.gov identifier: NCT00127881). The trial enrollment was suspended in October 2008 while Genmab was seeking a out-license agreement to further develop the compound. TenX Biopharma acquired global rights to zanolimumab in February, 2010 from Genmab.
› Verified 1 days ago
Michelle L Rush, MSN, APRN, BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-1711 | |
Mrs. Leslie Rhodes, PNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 51 N Dunlap St Ste 100, Memphis, TN 38105 Phone: 901-287-7337 Fax: 901-937-6681 | |
Gwendolyn Watson, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 201 Poplar Ave, Memphis, TN 38103 Phone: 901-545-2445 | |
Barbara A Overbey, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 825 Ridge Lake Blvd, Memphis, TN 38120 Phone: 901-685-2200 Fax: 901-259-2715 | |
Florida Allen, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3362 S 3rd St, Memphis, TN 38109 Phone: 901-701-2510 Fax: 901-260-8598 | |
Mrs. Sarah Michelle Wredling, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4066 Summer Ave, Memphis, TN 38122 Phone: 901-452-7391 | |
Teri Williams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3530 Hickory Hill Rd, Memphis, TN 38115 Phone: 901-881-6686 |